The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) today launched a joint continental preparedness and response plan to address the ongoing Ebola outbreak caused by the Bundibugyo virus. The plan aims to coordinate surveillance, laboratory testing, and community engagement across affected and at-risk countries.
According to WHO, as of June 7, 2026, there have been 23 confirmed cases and 11 deaths in Uganda and the Democratic Republic of the Congo. The outbreak was first declared in Uganda on May 15, 2026. The Bundibugyo virus is one of six species of Ebolavirus and has a lower fatality rate than Zaire ebolavirus but still poses significant public health risks.
Africa CDC has deployed 2,000 doses of an experimental vaccine specifically targeting the Bundibugyo strain, developed by the Uganda Virus Research Institute in collaboration with international partners. The vaccine is being offered to healthcare workers and close contacts of confirmed cases under emergency use authorization.
Dr. Jean Kaseya, Director General of Africa CDC, stated: 'This joint plan leverages the strengths of both organizations to stop the outbreak quickly and prevent further spread.' WHO Director-General Dr. Tedros Adhanom Ghebreyesus added: 'Our collaboration is critical to protecting communities and ensuring a coordinated response.'
The plan includes $15 million in initial funding from the WHO Contingency Fund for Emergencies and the Africa CDC Emergency Fund. Both organizations urge member states to enhance border surveillance and public awareness campaigns.
